Antibody-conjugated liposomes that specifically target NPM1 mutations represent a promising advancement in leukemia research, as they allow for precise delivery of therapeutic agents directly to affected cells. By utilizing antibodies that recognize and bind to the unique epitopes present on cells expressing NPM1 mutations, these liposomes significantly enhance the specificity of drug treatments while minimizing collateral damage to healthy cells. This targeted approach not only improves treatment efficacy but also holds the potential to reduce side effects and improve patient outcomes in leukemia therapies.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-711 | Recombinant Anti-human NPM1 Antibody | ELISA, WB, IP, FuncS | IgG |
MOB-0146F | Mouse Anti-NPM1 Recombinant Antibody (MOB-0146F) | IHC-P, IF | Mouse IgG |
ZG-0322F | Mouse Anti-NPM1 Recombinant Antibody (ZG-0322F) | WB, IF | Mouse IgG |
ZG-0323F | Mouse Anti-NPM1 Recombinant Antibody (ZG-0323F) | WB, IHC, IF, ELISA | Mouse IgG |
VS4-CJ58 | Recombinant Mouse Anti-NPM1 Antibody (VS4-CJ58) | ELISA, WB, ICC | Mouse IgG1 |
There are currently no Customer reviews or questions for VS-1024-FY157. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.